Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Bioresorbable vascular scaffolds and late lumen loss

In the ABSORB II trial pubilished in The Lancet, Patrick Serruys and colleagues (Nov 19, p 2479)1 concluded that compared with everolimus-eluting metallic stents, everolimus-eluting bioresorbable vascular scaffolds (BVSs) were inferior because the late luminal loss at 3 years was greater with the BVSs. However, one of the major risk factors for late luminal loss is under expansion of the stent at implantation, which can be attenuated by using optimum implantation techniques such as the use of routine intravascular imaging modalities (ie, intravascular ultrasound or optical coherence tomography) and high-pressure postdilatation.

email